1. A novel androgen‐reduced prostate‐specific lncRNA, PSLNR, inhibits prostate‐cancer progression in part by regulating the p53‐dependent pathway. Issue 12 (3rd July 2019) Authors: Wang, Dan; Wan, Xuechao; Zhang, Yalong; Kong, Zhe; Lu, Yali; Sun, Xian; Huang, Yan; Ji, Chaoneng; Li, Dujian; Luo, Jun; Gu, Wei; Wang, Chenji; Li, Yao; Xu, Yaoting Journal: Prostate Issue: Volume 79:Issue 12(2019) Page Start: 1379 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm. (20th April 2020) Authors: Luo, Jun; Xie, Yi; Zheng, Yuxiao; Wang, Chenji; Qi, Feng; Hu, Jiateng; Xu, Yaoting Journal: Cancer medicine Issue: Volume 9:Number 12(2020) Page Start: 4310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Integrative analysis of AR‐mediated transcriptional regulatory network reveals IRF1 as an inhibitor of prostate cancer progression. Issue 8 (13th April 2020) Authors: Cheng, Yihang; Wang, Dan; Jiang, Jun; Huang, Wenhua; Li, Dujian; Luo, Jun; Gu, Wei; Mo, Wenjuan; Wang, Chenji; Li, Yao; Gu, Shaohua; Xu, Yaoting Journal: Prostate Issue: Volume 80:Issue 8(2020) Page Start: 640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗